Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome.

Amro SehlyAlbert HeAbdul Rahman IhdayhidChristine GreyScott O'ConnorGillian GreenMatthew EricksonJames M RankinP Gerry FeganBu B YeapGirish DwivediNick S R Lan

Published in: Acta cardiologica (2024)

In patients with ACS and T2D, addition of empagliflozin to standard ACS therapy prior to discharge is associated with improved LA function.

Keyphrases

acute coronary syndrome
left atrial
atrial fibrillation
percutaneous coronary intervention
antiplatelet therapy
mitral valve
left ventricular
catheter ablation
stem cells
mesenchymal stem cells
coronary artery disease
bone marrow